[Therapy of hypertension].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects; D002543:Cerebral Hemorrhage / Q000209:etiology; D004232:Diuretics / Q000627:therapeutic use*; D004630:Emergencies; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000209:etiology / Q000628:therapy*; D010673:Pheochromocytoma / Q000150:complications; D011379:Prognosis; D012306:Risk; D013565:Sympatholytics / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D013565:Sympatholytics; D014665:Vasodilator Agents; D006145:Guanethidine
Die Therapie der Hypertonie.